Lyfnua

Gefapixant, the active ingredient in Lyfnua, is a P2X3 receptor antagonist presented as a 45 mg film-coated tablet for oral use. It is indicated for the treatment of chronic refractory or unexplained chronic cough in adults.

GNH USA supplies Lyfnua as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.

Lyfnua is used in the management of chronic cough conditions. It is specifically indicated for:

- Chronic refractory cough: Reduces coughing in patients who do not respond to standard treatments. - Unexplained chronic cough: Alleviates persistent coughing when the underlying cause is unknown. - Chronic cough in adults: Provides relief for adults suffering from long-term coughing issues.

Lyfnua may cause several side effects, which can be categorized as follows:

Common Side Effects: - Diarrhea: Frequent bowel movements or loose stools. - Dyspepsia: Indigestion or discomfort in the upper abdomen. - Nausea: Feeling of sickness or the urge to vomit. - Dry mouth: Reduced saliva production in the mouth. - Increased salivation: Excessive production of saliva. - Upper abdominal pain: Discomfort or pain in the upper stomach area. - Upper respiratory infection: Symptoms such as a runny nose, sore throat, or cough. - Cough: Persistent or worsening cough. - Oral hypoesthesia: Reduced sensation in the mouth. - Oral paresthesia: Tingling or numbness in the mouth. - Ageusia: Loss of taste. - Dysgeusia: Altered or distorted taste perception. - Hypogeusia: Reduced taste sensitivity. - Headache: Pain or discomfort in the head. - Dizziness: Feeling lightheaded or unsteady. - Bladder stones: Formation of stones in the bladder. - Kidney stones: Formation of stones in the kidneys. - Urinary tract stones: Formation of stones in the urinary tract. - Insomnia: Difficulty falling or staying asleep. - Reduced appetite: Decreased desire to eat.

Serious or Rare Side Effects: - Severe allergic reactions: Symptoms such as rash, itching, swelling, severe dizziness, or trouble breathing.

Lyfnua should be used with caution and certain precautions should be observed:

- Allergies: Inform your healthcare provider if you have any known allergies to gefapixant or any of the excipients in Lyfnua. - Pregnancy: It is best to avoid using Lyfnua if you are pregnant, as its safety during pregnancy has not been established. - Breastfeeding: Consult your healthcare provider before using Lyfnua while breastfeeding. - Sleep apnea: Inform your healthcare provider if you have sleep apnea, as Lyfnua may affect your breathing. - Severe kidney impairment: Use Lyfnua with caution if you have severe kidney impairment and are not undergoing dialysis. - Storage: Store below 25°C: Keep in the original pack, protect from moisture.

Lyfnua may interact with other medications, which can be categorized as follows:

Major Interactions (Avoid): - Sulfonamide allergies: Avoid Lyfnua if you are allergic to sulfonamides, as it may cause severe allergic reactions. - Severe kidney impairment: Avoid use in patients with severe kidney impairment who are not undergoing dialysis.

Moderate Interactions (Monitor Closely): - Other medications: Inform your healthcare provider about all medications you are taking to avoid potential interactions. - Sleep apnea: Monitor closely if you have sleep apnea, as Lyfnua may affect your breathing. - Kidney stones: Monitor for symptoms of kidney stones, such as pain in the back or side, blood in the urine, or painful urination.